Research Alliance Corp. II

Research Alliance Corp. II (Nasdaq: RACB) is a blank-check special purpose acquisition company that completed its initial public offering in 2021 with a focus on the life sciences and healthcare sector. Sponsored by Research Alliance Corp. II LLC, the vehicle represents the second SPAC from the same sponsor group, which targets opportunities at the intersection of research-driven healthcare and commercial-stage innovation. The May 2022 10-Q filing, submitted under accession number 0001104659-22-059541, reflects the company's status during its active search period for a qualifying business combination target. At the time of filing, RACB remained in its pre-merger phase. Visit SpacDesk and sign up for full access to RACB's filing history, sponsor details, and deal-status tracking.